Your browser version may not work well with NCBI's Web applications. More information here...
1: J Allergy Clin Immunol. 2003 Dec;112(6 Suppl):S140-50.Click here to read Links

Current management of atopic dermatitis and interruption of the atopic march.

Boguniewicz M, Eichenfield LF, Hultsch T.

Division of Pediatric Allergy-Immunology, National Jewish Medical Research Center and University of Colorado School of Medicine, Denver, Colorado 80206, USA.

Treatment of atopic dermatitis requires a comprehensive approach that includes evaluation of potential triggers and education of the patient and family regarding proper avoidance measures. Hydration of the skin and maintenance of an intact skin barrier remain integral to proper management. Although topical corticosteroids have been a mainstay of anti-inflammatory therapy, the newer topical calcineurin inhibitors offer advantages for treatment of this chronic, relapsing disease. Studies aimed at defining optimal combination therapy and early intervention might change the treatment paradigm for atopic dermatitis.

PMID: 14657844 [PubMed - indexed for MEDLINE]

Related Articles